599 related articles for article (PubMed ID: 25593033)
1. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
Pelletier J; Graff J; Ruggero D; Sonenberg N
Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
[TBL] [Abstract][Full Text] [Related]
3. Targeting the eIF4F translation initiation complex for cancer therapy.
Konicek BW; Dumstorf CA; Graff JR
Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
[TBL] [Abstract][Full Text] [Related]
4. Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation.
Bitterman PB; Polunovsky VA
Mol Cancer Ther; 2012 May; 11(5):1051-61. PubMed ID: 22572598
[TBL] [Abstract][Full Text] [Related]
5. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
[TBL] [Abstract][Full Text] [Related]
6. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.
Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of small molecules targeting eIF4A.
Naineni SK; Itoua Maïga R; Cencic R; Putnam AA; Amador LA; Rodriguez AD; Jankowsky E; Pelletier J
RNA; 2020 May; 26(5):541-549. PubMed ID: 32014999
[TBL] [Abstract][Full Text] [Related]
8. c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: implications for anticancer therapy.
Lin CJ; Malina A; Pelletier J
Cancer Res; 2009 Oct; 69(19):7491-4. PubMed ID: 19773439
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of the host translation initiation complex eIF4F by DNA viruses.
Walsh D
Biochem Soc Trans; 2010 Dec; 38(6):1511-6. PubMed ID: 21118117
[TBL] [Abstract][Full Text] [Related]
10. Emerging therapeutics targeting mRNA translation.
Malina A; Mills JR; Pelletier J
Cold Spring Harb Perspect Biol; 2012 Apr; 4(4):a012377. PubMed ID: 22474009
[TBL] [Abstract][Full Text] [Related]
11. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
12. Many roads from mTOR to eIF4F.
Thoreen CC
Biochem Soc Trans; 2013 Aug; 41(4):913-6. PubMed ID: 23863155
[TBL] [Abstract][Full Text] [Related]
13. m
Coots RA; Liu XM; Mao Y; Dong L; Zhou J; Wan J; Zhang X; Qian SB
Mol Cell; 2017 Nov; 68(3):504-514.e7. PubMed ID: 29107534
[TBL] [Abstract][Full Text] [Related]
14. mTOR signaling: implications for cancer and anticancer therapy.
Petroulakis E; Mamane Y; Le Bacquer O; Shahbazian D; Sonenberg N
Br J Cancer; 2006 Jan; 94(2):195-9. PubMed ID: 16404421
[TBL] [Abstract][Full Text] [Related]
15. The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment.
Bartish M; Abraham MJ; Gonçalves C; Larsson O; Rolny C; Del Rincón SV
Nat Rev Cancer; 2023 Jun; 23(6):408-425. PubMed ID: 37142795
[TBL] [Abstract][Full Text] [Related]
16. Formation of the eIF4F translation-initiation complex determines sensitivity to anticancer drugs targeting the EGFR and HER2 receptors.
Zindy P; Bergé Y; Allal B; Filleron T; Pierredon S; Cammas A; Beck S; Mhamdi L; Fan L; Favre G; Delord JP; Roché H; Dalenc F; Lacroix-Triki M; Vagner S
Cancer Res; 2011 Jun; 71(12):4068-73. PubMed ID: 21498638
[TBL] [Abstract][Full Text] [Related]
17. SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex.
Feng Y; Pinkerton AB; Hulea L; Zhang T; Davies MA; Grotegut S; Cheli Y; Yin H; Lau E; Kim H; De SK; Barile E; Pellecchia M; Bosenberg M; Li JL; James B; Hassig CA; Brown KM; Topisirovic I; Ronai ZA
Cancer Res; 2015 Dec; 75(24):5211-8. PubMed ID: 26603897
[TBL] [Abstract][Full Text] [Related]
18. Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma.
Robert F; Roman W; Bramoullé A; Fellmann C; Roulston A; Shustik C; Porco JA; Shore GC; Sebag M; Pelletier J
Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13421-6. PubMed ID: 25197055
[TBL] [Abstract][Full Text] [Related]
19. Targeting the eIF4A RNA helicase as an anti-neoplastic approach.
Chu J; Pelletier J
Biochim Biophys Acta; 2015 Jul; 1849(7):781-91. PubMed ID: 25234619
[TBL] [Abstract][Full Text] [Related]
20. Developing anti-neoplastic biotherapeutics against eIF4F.
Steinberger J; Chu J; Maïga RI; Sleiman K; Pelletier J
Cell Mol Life Sci; 2017 May; 74(9):1681-1692. PubMed ID: 28004147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
